Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: A meta-analysis of genetic studies and randomised trials

The Lancet

Volumn 378, Issue 9791, 2011, Pages 584-594

  Holmes, Michael V ^a   Newcombe, Paul ^c,d   Hubacek, Jaroslav A ^e   Sofat, Reecha ^a   Ricketts, Sally L ^f   Cooper, Jackie ^a   Breteler, Monique Mb ^j,k   Bautista, Leonelo E ^l   Sharma, Pankaj ^m   Whittaker, John C ^c,d   Smeeth, Liam ^c   Fowkes, F Gerald R ⁿ   Algra, Ale ^o,r   Shmeleva, Veronika ^p   Szolnoki, Zoltan ^q   Roest, Mark ^r   Linnebank, Michael ^s   Zacho, Jeppe ^t   Nalls, Michael A ^u   Singleton, Andrew B ^u   Ferrucci, Luigi ^v   Hardy, John ^b   Worrall, Bradford B ^w   Rich, Stephen S ^w   Matarin, Mar ^a   Norman, Paul E ^x   Flicker, Leon ^y,z   Almeida, Osvaldo P ^x,z,aa   Van Bockxmeer, Frank M ^x,aa   Shimokata, Hiroshi ^ab   Khaw, Kay Tee ^g   Wareham, Nicholas J ^h   Bobak, Martin ^a   Sterne, Jonathan A C ^ac   Smith, George Davey ^ac   Talmud, Philippa J ^a   Van Duijn, Cornelia ^j   Humphries, Steve E ^a   Price, Jackie F ⁿ   Ebrahim, Shah ^c   Lawlor, Debbie A ^ac   Hankey, Graeme J ^y   Meschia, James F ^ad   Sandhu, Manjinder S ^h,i   Hingorani, Aroon D ^a   Casas, Juan P ^a,c   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^j ERASMUS MEDICAL CENTER   (Netherlands)

^k GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^l UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^m IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁿ UNIVERSITY OF EDINBURGH   (United Kingdom)

^o LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^p Russian Institute of Haematology and Transfusion   (Russian Federation)

^q Pandy County Hospital   (Hungary)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^t GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^u NATIONAL INSTITUTES OF HEALTH   (United States)

^v NATIONAL INSTITUTE ON AGING   (United States)

^w UNIVERSITY OF VIRGINIA   (United States)

^x UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^y UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^z UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^aa ROYAL PERTH HOSPITAL   (Australia)

^ab NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^ac UNIVERSITY OF BRISTOL   (United Kingdom)

^ad MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ASIA; AUSTRALIA; GENETIC ANALYSIS; GENOTYPE; HEALTH CARE POLICY; HUMAN; LIFESTYLE MODIFICATION; META ANALYSIS; NEW ZEALAND; POPULATION RISK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; STROKE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; WESTERN HEMISPHERE;

EID: 80051695692     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60872-6     Document Type: Article

References (62)

1. DS Wald, M Law, JK Morris Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis BMJ 325 2002 1202
2. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2002 2015 2022
3. L Brattstrom, DE Wilcken Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72 2000 315 323 (Pubitemid 30620632)
4. PM Ueland, H Refsum, SA Beresford, SE Vollset The controversy over homocysteine and cardiovascular risk Am J Clin Nutr 72 2000 324 332 (Pubitemid 30623491)
5. G Davey Smith, S Ebrahim 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32 2003 1 22 (Pubitemid 36503465)
6. A Hingorani, S Humphries Nature's randomised trials Lancet 366 2005 1906 1908 (Pubitemid 41713974)
7. NA Sheehan, V Didelez, PR Burton, MD Tobin Mendelian randomisation and causal inference in observational epidemiology PLoS Med 5 2008 e177
8. M Klerk, P Verhoef, R Clarke, HJ Blom, FJ Kok, EG Schouten MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis JAMA 288 2002 2023 2031 (Pubitemid 35204693)
9. SJ Lewis, S Ebrahim, G Davey Smith Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 331 2005 1053
10. JP Casas, LE Bautista, L Smeeth, P Sharma, AD Hingorani Homocysteine and stroke: evidence on a causal link from mendelian randomisation Lancet 365 2005 224 232 (Pubitemid 40138016)
11. S Hustad, O Midttun, J Schneede, SE Vollset, T Grotmol, PM Ueland The methylenetetrahydrofolate reductase 677C→T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism Am J Hum Genet 80 2007 846 855 (Pubitemid 46668453)
12. SE Chiuve, EL Giovannucci, SE Hankinson et al. Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine Am J Clin Nutr 82 2005 155 162 (Pubitemid 41716388)
13. A de Bree, WM Verschuren, AL Bjorke-Monsen et al. Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample Am J Clin Nutr 77 2003 687 693 (Pubitemid 36258581)
14. K He, A Merchant, EB Rimm et al. Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men Stroke 35 2004 169 174 (Pubitemid 38057614)
15. L Sharp, J Little, NT Brockton et al. Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake Br J Nutr 99 2008 379 389
16. M Eichholzer, O Tönz, R Zimmermann Folic acid: a public-health challenge Lancet 367 2006 1352 1361
17. X Wang, X Qin, H Demirtas et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis Lancet 369 2007 1876 1882 (Pubitemid 46829358)
18. Little J, Higgins J, eds. HuGE review handbook. http://www.hugenet.org. uk/resources/handbook.php (accessed April 11, 2010).
19. Higgins J, Green S, eds. Cochrane handbook for systematic reviews of interventions, version 5.0.2. The Cochrane Collaboration 2009. www.cochrane-handbook.org (accessed April 11, 2010).
20. M Egger, G Davey Smith, M Schneider, C Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634 (Pubitemid 27387172)
21. S Duval, R Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463 (Pubitemid 30422636)
22. R Lawrence, AG Day-Williams, R Mott, J Broxholme, LR Cardon, E Zeggini GLIDERS - a web-based search engine for genome-wide linkage disequilibrium between HapMap SNPs BMC Bioinformatics 10 2009 367
23. LA Hindorff, HA Junkins, PN Hall, JP Mehta, TA Manolio A catalog of published genome-wide association studies www.genome.gov/gwastudies (accessed April 30, 2010).
24. JP Higgins, SG Thompson, JJ Deeks, DG Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
25. L Zhu, H Ling National neural tube defects prevention program in China Food Nutr Bull 29 2 suppl 2008 S196 S204
26. BI Somarajan, J Kalita, B Mittal, UK Misra Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients. A case-control study in a Northern Indian population J Neurol Sciences 304 2011 67 70
27. CM Li, C Zhang, XL Lu et al. Relationship between methylenetrahydrofolate reductase gene and ischemic stroke Chin Crit Care Med 18 2006 264 267 (Pubitemid 43826637)
28. Y Yamada, N Metoki, H Yoshida et al. Genetic risk for ischemic and hemorrhagic stroke Arterioscler Thromb Vasc Biol 26 2006 1920 1925 (Pubitemid 44305351)
29. Z Li, L Sun, H Zhang et al. Multicenter Case-Control Study in China. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case-control study in China Stroke 34 2003 2085 2090 (Pubitemid 37099816)
30. A Hofman, MM Breteler, CM van Duijn et al. The Rotterdam Study: 2010 objectives and design update Eur J Epidemiol 24 2009 553 572
31. J Frederiksen, K Juul, P Grande et al. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study Blood 104 2004 3046 3051 (Pubitemid 39507118)
32. K Kostulas, VH Brophy, K Moraitis et al. Genetic profile of ischemic cerebrovascular disease and carotid stenosis Acta Neurol Scand 118 2008 146 152
33. Z Szolnoki, V Havasi, J Bene et al. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke Acta Neurol Scand 111 2005 29 33
34. W Lalouschek, G Endler, M Schillinger et al. Candidate genetic risk factors of stroke: results of a multilocus genotyping assay Clin Chem 53 2007 600 605 (Pubitemid 46580228)
35. N Day, S Oakes, R Luben et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer Br J Cancer 80 suppl 1 1999 95 103 (Pubitemid 29389613)
36. Z Szolnoki, F Somogyvari, A Kondacs et al. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke J Neurol Neurosurg Psychiatry 74 2003 1615 1620 (Pubitemid 37542048)
37. JF Meschia, TG Brott, RD Brown Jr et al. The Ischemic Stroke Genetics Study (ISGS) protocol BMC Neurol 3 2003 4
38. JF Meschia, RD Brown Jr, TG Brott, FE Chukwudelunzu, J Hardy, SS Rich The Siblings With Ischemic Stroke Study (SWISS) protocol BMC Med Genet 3 2002 1
39. JP Ioannidis, P Boffetta, J Little et al. Assessment of cumulative evidence on genetic associations: interim guidelines Int J Epidemiol 37 2008 120 132 (Pubitemid 351228620)
40. G Pare, DI Chasman, AN Parker et al. Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study Circ Cardiovasc Genet 2 2009 142 150
41. C Newton-Cheh, T Johnson, V Gateva et al. Genome-wide association study identifies eight loci associated with blood pressure Nat Genet 41 2009 666 676
42. A Liem, GH Reynierse-Buitenwerf, AH Zwinderman, JW Jukema, DJ van Veldhuisen Secondary prevention with folic acid: results of the Goes extension study Heart 91 2005 1213 1214 (Pubitemid 41192405)
43. M Ebbing, O Bleie, PM Ueland et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial JAMA 300 2008 795 804
44. KH Bonaa, I Njolstad, PM Ueland et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction N Engl J Med 354 2006 1578 1588
45. M Righetti, P Serbelloni, S Milani, G Ferrario Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients Blood Purif 24 2006 379 386 (Pubitemid 44215183)
46. JM Armitage on behalf of the SEARCH Study Collaborative Group Late-breaking clinical trial abstracts from the American Heart Association's Scientific Sessions 2008. Abstract S165: SEARCH (Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine): randomized comparison of folic acid 2 mg plus vitamin b12 1 mg daily versus placebo for 7 years in 12 064 myocardial infarction survivors Circulation 118 2008 2310
47. The VITATOPS Trial Study Group B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial Lancet Neurol 9 2010 855 865
48. E Lonn, S Yusuf, MJ Arnold et al. Homocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 354 2006 1567 1577
49. AA House, M Eliasziw, DC Cattran et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial JAMA 303 2010 1603 1609
50. S Zoungas, BP McGrath, P Branley et al. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial J Am Coll Cardiol 47 2006 1108 1116
51. EM Wrone, JM Hornberger, JL Zehnder, LM McCann, NS Coplon, SP Fortmann Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease J Am Soc Nephrol 15 2004 420 426 (Pubitemid 38140783)
52. RL Jamison, P Hartigan, JS Kaufman et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial JAMA 298 2007 1163 1170 (Pubitemid 47403102)
53. CM Albert, NR Cook, JM Gaziano et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial JAMA 299 2008 2027 2036 (Pubitemid 351656584)
54. JF Toole, MR Malinow, LE Chambless et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 291 2004 565 575 (Pubitemid 38500310)
55. R Clarke, J Halsey, S Lewington et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals Arch Intern Med 170 2010 1622 1631
56. R Clarke, J Armitage, S Lewington, R Collins Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis Clin Chem Lab Med 45 2007 1575 1581 (Pubitemid 350232974)
57. Z Chen, L Lee, J Chen et al. Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC) Int J Epidemiol 34 2005 1243 1249 (Pubitemid 41819529)
58. F Drenos, PJ Talmud, JP Casas et al. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk Hum Mol Genet 18 2009 2305 2316
59. LL Stern, JB Mason, J Selhub, SW Choi Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene Cancer Epidemiol Biomarkers Prev 9 2000 849 853 (Pubitemid 30660060)
60. MY Tsai, CM Loria, J Cao et al. Polygenic association with total homocysteine in the post-folic acid fortification era: the CARDIA study Mol Genet Metab 98 2009 181 186
61. K Strong, C Mathers, R Bonita Preventing stroke: saving lives around the world Lancet Neurol 6 2007 182 187 (Pubitemid 46097543)
62. China Stroke Primary Prevention Trial (CSPPT) NCT00794885 http://clinicaltrials.gov/ct2/show/NCT00794885 (accessed December, 2010).